Arete Wealth Advisors LLC Purchases Shares of 10,185 Hims & Hers Health, Inc. $HIMS

Key Points

• Arete Wealth Advisors LLC acquired 10,185 shares of Hims & Hers Health, valued at approximately $300,000, marking a new investment during the 1st quarter.
• Institutional investors now hold 63.52% of Hims & Hers Health's shares, with notable increases in holdings from firms like Northern Trust Corp and Yong Rong HK Asset Management Ltd.
• Hims & Hers Health reported earnings of $0.17 per share for the last quarter, falling short of analysts' expectations, while their quarterly revenue rose 72.6% year-over-year, amounting to $544.83 million.

Arete Wealth Advisors LLC acquired a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,185 shares of the company's stock, valued at approximately $300,000.

A number of other institutional investors also recently modified their holdings of the stock. Northern Trust Corp grew its holdings in Hims & Hers Health by 19.5% in the first quarter. Northern Trust Corp now owns 2,435,512 shares of the company's stock worth $71,969,000 after purchasing an additional 397,310 shares during the period. Yong Rong HK Asset Management Ltd boosted its position in shares of Hims & Hers Health by 41.2% during the 1st quarter. Yong Rong HK Asset Management Ltd now owns 2,400,000 shares of the company's stock worth $70,920,000 after purchasing an additional 700,100 shares in the last quarter. Nuveen LLC bought a new position in shares of Hims & Hers Health during the 1st quarter worth about $58,403,000. Two Sigma Investments LP grew its stake in shares of Hims & Hers Health by 37.9% in the 4th quarter. Two Sigma Investments LP now owns 1,967,354 shares of the company's stock valued at $47,571,000 after buying an additional 540,274 shares during the period. Finally, BIT Capital GmbH increased its position in Hims & Hers Health by 7.4% in the 1st quarter. BIT Capital GmbH now owns 1,642,493 shares of the company's stock valued at $48,536,000 after buying an additional 112,949 shares in the last quarter. Institutional investors and hedge funds own 63.52% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. UBS Group set a $30.00 price target on Hims & Hers Health in a report on Monday, June 23rd. Wall Street Zen cut Hims & Hers Health from a "buy" rating to a "hold" rating in a report on Monday, July 28th. Needham & Company LLC reissued a "hold" rating on shares of Hims & Hers Health in a research report on Tuesday, August 5th. Zacks Research downgraded shares of Hims & Hers Health from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 19th. Finally, Morgan Stanley reaffirmed an "equal weight" rating and issued a $40.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, June 11th. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Hims & Hers Health currently has a consensus rating of "Reduce" and a consensus target price of $38.92.

Insider Buying and Selling

In other Hims & Hers Health news, insider Soleil Boughton sold 2,571 shares of the business's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $44.53, for a total value of $114,486.63. Following the sale, the insider directly owned 150,450 shares in the company, valued at $6,699,538.50. The trade was a 1.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Michael Chi sold 2,100 shares of the stock in a transaction on Thursday, July 24th. The stock was sold at an average price of $57.52, for a total value of $120,792.00. Following the transaction, the insider owned 278,654 shares of the company's stock, valued at $16,028,178.08. The trade was a 0.75% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,384,728 shares of company stock worth $71,149,098 in the last three months. Insiders own 13.71% of the company's stock.

Hims & Hers Health Trading Up 8.4%

Shares of Hims & Hers Health stock opened at $51.78 on Friday. Hims & Hers Health, Inc. has a 1 year low of $15.19 and a 1 year high of $72.98. The firm has a market cap of $11.70 billion, a PE ratio of 64.73, a P/E/G ratio of 3.23 and a beta of 2.14. The stock has a fifty day moving average price of $50.11 and a 200-day moving average price of $45.14. The company has a debt-to-equity ratio of 1.72, a current ratio of 4.98 and a quick ratio of 4.46.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The company had revenue of $544.83 million during the quarter, compared to analysts' expectations of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.Hims & Hers Health's quarterly revenue was up 72.6% compared to the same quarter last year. During the same period last year, the firm posted $0.06 earnings per share. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Want to see what other hedge funds are holding HIMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hims & Hers Health, Inc. (NYSE:HIMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.